Nurix Therapeutics (NRIX) Current Assets (2019 - 2025)
Historic Current Assets for Nurix Therapeutics (NRIX) over the last 7 years, with Q4 2025 value amounting to $606.8 million.
- Nurix Therapeutics' Current Assets fell 202.91% to $606.8 million in Q4 2025 from the same period last year, while for Nov 2025 it was $606.8 million, marking a year-over-year decrease of 202.91%. This contributed to the annual value of $606.8 million for FY2025, which is 202.91% down from last year.
- According to the latest figures from Q4 2025, Nurix Therapeutics' Current Assets is $606.8 million, which was down 202.91% from $440.6 million recorded in Q3 2025.
- In the past 5 years, Nurix Therapeutics' Current Assets ranged from a high of $619.4 million in Q4 2024 and a low of $251.0 million during Q1 2024
- Moreover, its 5-year median value for Current Assets was $336.7 million (2022), whereas its average is $384.1 million.
- Per our database at Business Quant, Nurix Therapeutics' Current Assets crashed by 2449.4% in 2023 and then skyrocketed by 12461.06% in 2025.
- Over the past 5 years, Nurix Therapeutics' Current Assets (Quarter) stood at $311.1 million in 2021, then grew by 2.36% to $318.4 million in 2022, then decreased by 7.21% to $295.5 million in 2023, then skyrocketed by 109.6% to $619.4 million in 2024, then fell by 2.03% to $606.8 million in 2025.
- Its last three reported values are $606.8 million in Q4 2025, $440.6 million for Q3 2025, and $515.3 million during Q2 2025.